Resistin-like molecule-beta (RELM-β) is a member of the resistin-like molecule (RELM) family, which includes highly cysteine-rich proteins such as RELMα, RELMβ, Resistin, and RELMγ . These proteins are involved in various physiological and pathological processes, including inflammation, cell proliferation, glucose metabolism, and barrier defense .
RELM-β is a non-glycosylated, disulfide-linked homodimer. Each monomer contains 89 amino acids, with the dimer having a total molecular weight of 19 kDa . The human recombinant version of RELM-β is produced in E. coli and includes a His-tag for purification purposes . The His-tag consists of 12 additional amino acid residues, making it easier to isolate and purify the protein using affinity chromatography .
RELM-β plays a significant role in various biological processes. It is involved in the inflammatory response, cell proliferation, glucose metabolism, and barrier defense . RELM-β has been shown to recruit CD4+ T cells during infectious colitis, promoting protective intestinal epithelial cell proliferation . It also exhibits antimicrobial activity against Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA) .
Recombinant human RELM-β is used primarily for research purposes. It is employed in studies investigating its role in inflammation, glucose metabolism, and barrier defense . The protein is also used to explore its potential as a therapeutic target for various diseases, including lung diseases, intestinal diseases, cardiovascular diseases, and cancers .